Page 66 - Read Online

MacLennan et al. Mini-invasive Surg 2023;7:23 Mini-invasive Surgery
DOI: 10.20517/2574-1225.2023.66

Editorial Open Access

The need for core outcome sets in renal cancer

clinical effectiveness research

3,4
4
1
1
2
Steven MacLennan , Lisa M Wintner , Muhammad Imran Omar , Katharina Beyer , Ailbhe Lawlor , Sheela
8,9
5,6
10
7
1
Tripathee , Saeed Dabestani , Lorenzo Marconi , Rachel H Giles , Rose Woodward , Mieke Van
4
Hemelrijck , Axel Bex 11,12,13 , Patricia Zondervan 14
1
Academic Urology Unit, Institute of Applied Health Sciences, University of Aberdeen, Aberdeen AB25 2ZD, UK.
2
University Hospital of Psychiatry II, Medical University of Innsbruck, Innsbruck 6020, Austria.
3
Department of Urology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam 3015, the Netherlands.
4
Translational Oncology and Urology Research (TOUR), King’s College London, London WC2R 2LS, UK.
5
Department of Translational Medicine, Division of Urological Cancers, Lund University, Lund 22100, Sweden.
6
Department of Urology, Kristianstad Central Hospital, Region Skane, Kristianstad 29133, Sweden.
7
Department of Urology, Coimbra University Hospital, Coimbra 3000, Portugal.
8
International Kidney Cancer Coalition, Duivendrecht 1115 HB, the Netherlands.
9
UMC Utrecht Cancer Center, Utrecht 3541, the Netherlands.
10
Action Kidney Cancer Charity, Manchester 06040, UK.
11
Department of Urology, The Netherlands Cancer Institute, Amsterdam 1013, the Netherlands.
12
Specialist Centre for Kidney Cancer, Royal Free Hospital, London NW3 2QG, UK.
13
University College London, Division of Surgery and Interventional Science, London NW3 2PS, UK.
14
Department of Urology, Amsterdam University Medical Centers, Amsterdam 1013, the Netherlands.
Correspondence to: Dr. Steven MacLennan, Academic Urology Unit, Institute of Applied Health Sciences, University of
Aberdeen, Foresterhill, Aberdeen, AB25 2ZD, UK. E-mail: steven.maclennan@abdn.ac.uk
How to cite this article: MacLennan S, Wintner LM, Omar MI, Beyer K, Lawlor A, Tripathee S, Dabestani S, Marconi L, Giles RH,
Woodward R, Van Hemelrijck M, Bex A, Zondervan P. The need for core outcome sets in renal cancer clinical effectiveness
research. Mini-invasive Surg 2023;7:23. https://dx.doi.org/10.20517/2574-1225.2023.66
Received: 20 Jun 2023 Accepted: 27 Jun 2023 Published: 28 Jun 2023
Academic Editor: Hendrik Van Poppel Copy Editor: Pei-Yun Wang Production Editor: Pei-Yun Wang
Keywords: Renal cancer, effectiveness research, core outcome set, systematic reviews, meta-analysis, clinical
practice guideline
Other contributions in this Special Issue discuss current management strategies of small renal masses,
whereas the aim of our contribution is to create awareness about how outcome reporting heterogeneity is a
major problem when evaluating the effectiveness of renal cancer treatment strategies, how this impacts
renal cancer care and how this problem can be overcome. To do this, it is necessary to summarise how
knowledge is produced and applied in medical research and the synthesis of study results.

© The Author(s) 2023. Open Access This article is licensed under a Creative Commons Attribution 4.0
International License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, sharing,
adaptation, distribution and reproduction in any medium or format, for any purpose, even commercially, as
long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and
indicate if changes were made.

www.misjournal.net